{"transactions":[{"id":701652,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28093,"kind":"person","name":"Martin Christopher Nathan","position":1,"cik":"0002097992","reported_name":"Martin Christopher Nathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit (RSU)","published_at":"2026-07-29T21:24:15.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":16700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock at settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the RSU, the shares underlying the RSU vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":16700,"derivative":{"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":16700},"source":{"system":"sec-edgar","filing":"0001193125-26-324256","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526324256/ownership.xml","form_type":"4"}},{"id":701651,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28093,"kind":"person","name":"Martin Christopher Nathan","position":1,"cik":"0002097992","reported_name":"Martin Christopher Nathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-29T21:24:15.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 100% on the earlier of July 27, 2027 or the date immediately prior to the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":25000,"derivative":{"exercise_price":6.18,"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-324256","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526324256/ownership.xml","form_type":"4"}},{"id":736214,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":28093,"kind":"person","name":"Martin Christopher Nathan","position":1,"cik":"0002097992","reported_name":"Martin Christopher Nathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2026-06-16T22:16:53.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":16377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 5, 2026 will become vested on the earlier of (i) June 5, 2027 or (ii) the business day prior to the 2027 annual meeting of stockholder."}],"balance_after":16377,"derivative":{"exercise_price":35.59,"exercise_date":"2027-06-02","expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":16377},"source":{"system":"sec-edgar","filing":"0002097992-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000209799226000001/primarydocument.xml","form_type":"4"}},{"id":753111,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":28093,"kind":"person","name":"Martin Christopher Nathan","position":1,"cik":"0002097992","reported_name":"Martin Christopher Nathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T20:49:13.000Z","date":"2026-06-02","kind":"grant","planned":false,"acquired":true,"shares":9136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/12 of the underlying shares monthly from June 2, 2026."}],"balance_after":9136,"derivative":{"exercise_price":55.23,"expiration_date":"2036-06-01","underlying":"Common Stock","underlying_shares":9136},"source":{"system":"sec-edgar","filing":"0000907654-26-000050","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000050/form4.xml","form_type":"4"}},{"id":781460,"issuer":{"id":5072,"kind":"organization","name":"ACHIEVE LIFE SCIENCES, INC.","symbol":"ACHV"},"owners":[{"id":28093,"kind":"person","name":"Martin Christopher Nathan","position":1,"cik":"0002097992","reported_name":"Martin Christopher Nathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-13T20:35:04.000Z","date":"2026-05-11","kind":"grant","planned":false,"acquired":true,"shares":47250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in substantially equal monthly installments over 36 months commencing May 11, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":47250,"derivative":{"exercise_price":5.59,"expiration_date":"2036-05-11","underlying":"Common Stock","underlying_shares":47250},"source":{"system":"sec-edgar","filing":"0001193125-26-221774","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/949858/000119312526221774/ownership.xml","form_type":"4"}},{"id":973299,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":28093,"kind":"person","name":"Martin Christopher Nathan","position":1,"cik":"0002097992","reported_name":"Martin Christopher Nathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-11T21:41:00.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/36 of the underlying shares monthly from December 11, 2025."}],"balance_after":35000,"derivative":{"exercise_price":30.21,"expiration_date":"2035-12-10","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000907654-25-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765425000019/form4.xml","form_type":"4"}},{"id":990057,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":28093,"kind":"person","name":"Martin Christopher Nathan","position":1,"cik":"0002097992","reported_name":"Martin Christopher Nathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2025-11-25T00:08:49.000Z","date":"2025-11-19","kind":"grant","planned":false,"acquired":true,"shares":45150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest each month beginning on December 19, 2025, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":45150,"derivative":{"exercise_price":22.34,"expiration_date":"2035-11-19","underlying":"Common Stock","underlying_shares":45150},"source":{"system":"sec-edgar","filing":"0002097992-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000209799225000005/primarydocument.xml","form_type":"4"}}]}